Controlled ovarian hyperstimulation: an adjunct to assisted reproductive technology

Area of Science:

• Reproductive endocrinology and infertility
• Assisted reproductive technologies (ART)
• Clinical trial methodology

Background:

• Many couples face infertility due to male factors, endometriosis, or unexplained causes.
• Access to advanced Assisted Reproductive Technologies (ART) facilities can be limited.
• Controlled ovarian hyperstimulation (COH) is a fertility treatment that stimulates egg production.

Purpose of the Study:

• To evaluate the efficacy of COH for couples with male factor, endometriosis, and unexplained infertility.
• To assess COH's value in settings without access to ART facilities.
• To compare COH outcomes against spontaneous cycles and untreated controls.

Main Methods:

• A study group received COH, including patients with male factor, endometriosis, and unexplained infertility.
• Outcomes were compared to the participants' own spontaneous cycles.
• A control group received no treatment but underwent scanning.

Main Results:

• COH demonstrated significantly better outcomes for unexplained infertility compared to spontaneous cycles or controls.
• COH was not found to be significantly effective for male factor infertility.
• Effectiveness for endometriosis-related infertility was not explicitly detailed but implied within the overall context.

Conclusions:

• COH is a valuable treatment option for unexplained infertility, particularly in resource-limited settings.
• Routine offering of COH in general hospitals is recommended for couples awaiting ART.
• COH may help couples facing enforced expectant management while on ART waiting lists.